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Matrix metalloprotease inhibitors
Matrix metalloproteases (MMPs) are a large family of zinc-dependent endoproteases involved
in the remodelling of connective tissue. The enzymes can be divided into four main groups:
collagenases, gelatinases, stromelysins and membrane type MMPs. Abnormal expression and
regulation of this group of enzymes has been directly implicated in the development of a
number of pathological conditions including rheumatoid arthritis, cancer invasion and
metastasis. A combinatorial approach using positional scanning techniques has been used to
identify agents with activity against a number of pathologically important MMPs (Solid-phase
synthesis and biological screening of N-α-mercaptoamide template-based matrix
metalloprotease inhibitors, J. F. Lynas et al., Combinatorial Chemistry & High Throughput
Screening, 3, (2000), 37-41). A small library of 40 compounds were individually synthesised
on Rink amide AM solid support using a positional scan of twenty amino acids at position Xxx
of (i) and (ii) respectively. Several of the compounds synthesised provided reasonably potent
compounds for MMP-1 or MMP-8 over other MMPs tested. For example (i) with Xxx = Trp
had an IC50 for MMP-1 of 50 nM, and selectivities of between 3 and 79 fold over MMPs 2, 3,
8 and 9. Whereas (ii) with Xxx = Nva, possessed an IC50 value of 240 nM against MMP-8,
and selectivities of between 0.5 and 16 fold over other MMPs tested. By screening these
compounds it was possible to identify which peripheral groups made the greatest contribution
to binding. This work has allowed identification of alternate pharmacophores which might be
used to focus the design and development of new libraries of MMP inhibitors with enhanced
selectivity for individual species.
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Selective dopamine D4 ligands
Hyperactivity of the dopaminergic system has long been linked to the etiology of
schizophrenia. Several dopamine receptor subtypes have been discovered which can be divided
into "D1-like" (D1, D5) or "D2-like" (D2, D3, D4). Typical antipsychotics effectively block both
the D4 and D2 receptors. It is hypothesised that D4 blockade imparts the neuroleptic effect of
the typical antipsychotics and the D2 blockade is responsible for the unwanted extrapyramidal
side effects. Thus a selective D4 antagonist would represent an effective treatment for
schizophrenia. The use of combinatorial chemistry in the discovery of novel inhibitors selective
for D4 over D2 is described in a recent paper (A solution-phase combinatorial synthesis of
selective dopamine D4 ligands, J. P. Williams and K. Lavrador, Combinatorial Chemistry &
High Throughput Screening, 3, (2000), 43-50).
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A library of 332 individual oxadiazolylpiperidines based on the core motif (iii) was prepared in
solution, and the products purified by preparative LC-MS using mass triggered sample
collection. One of the most potent and selective compounds (hD4 vs. hD2) isolated from this
library was (iv) which possessed a Kd of 5 nM against human D4, with better than 50 fold
selectivity over human D2. The authors have combined combinatorial synthesis with automated
purification to deliver, in only one round of synthesis, a new series of selective dopamine D4
ligands based on the 1,2,4-oxadiazole bioisostere of the ester group.
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